Mo Y Y, Seshu J, Wang D, Mallavia L P
Department of Microbiology, Washington State University, Pullman, WA 99164-4233, USA.
Biochem J. 1998 Oct 1;335 ( Pt 1)(Pt 1):67-77. doi: 10.1042/bj3350067.
FK506-binding proteins (FKBPs) have been identified in a variety of eukaryotic and prokaryotic organisms. Macrophage infectivity potentiator (CbMip, 23.5 kDa) protein of the obligate intracellular bacterium, Coxiella burnetii, was shown previously to belong to the family of FKBPs based on sequence homology and peptidyl-prolyl cis/trans isomerase (PPIase) activity. Further characterization of the cbmip gene has identified two additional proteins with molecular masses of 15.5 and 15.0 kDa that are synthesized, in addition to the 23.5 kDa CbMip, when expressed in Escherichia coli. Amino acid sequencing at the N-terminus combined with transcription and translation fusion expression revealed that the two proteins were synthesized from the same open reading frame of the cbmip gene, but starting at different internal translation start codons, probably by translational reinitiation. When the internal methionines serving as start sites were replaced with lysine by site-directed mutagenesis, the synthesis of 15.5 and 15.0 kDa proteins was abolished even though the synthesis of 23.5 kDa CbMip was intact. This confirmed that the 15.5 and 15.0 kDa proteins are indeed generated by translational reinitiation and are not degradation products of the 23.5 kDa protein. Like other FKBPs, both 15.5 and 15.0 kDa proteins exhibit PPIase activity. Because they share significant sequence homology with FKBPs and have a similar PPIase activity, 15.5 and 15. 0 kDa proteins are designated as C. burnetii FKBP (Cb-FKBP) analogues I and II, respectively. TnphoA mutagenesis demonstrated that whereas the large protein (CbMip) is secreted, Cb-FKBP analogues I and II are cytoplasmic, indicating that structural variations could allow for different subcellular compartmentalization of similar proteins. Western-blot analysis of lysates of purified C. burnetii using a CbMip-specific monoclonal antibody revealed the presence of a protein migrating at approximately 15 kDa, indicating the presence of smaller Cb-FKBP analogue(s) in C. burnetii, although at much lower levels compared with 23.5 kDa CbMip. This unique gene organization seen with cbmip may provide the organism with a mechanism of efficient use of its limited genetic information to synthesize proteins that are structurally different yet functionally similar.
FK506结合蛋白(FKBPs)已在多种真核生物和原核生物中被鉴定出来。先前研究表明,专性胞内细菌伯纳特立克次体的巨噬细胞感染增强因子(CbMip,23.5 kDa)蛋白基于序列同源性和肽基脯氨酰顺反异构酶(PPIase)活性,属于FKBPs家族。对cbmip基因的进一步表征发现,除了23.5 kDa的CbMip外,当在大肠杆菌中表达时,还会合成另外两种分子量分别为15.5 kDa和15.0 kDa的蛋白质。N端氨基酸测序结合转录和翻译融合表达表明,这两种蛋白质由cbmip基因的同一个开放阅读框合成,但起始于不同的内部翻译起始密码子,可能是通过翻译重新起始。当通过定点诱变将作为起始位点的内部甲硫氨酸替换为赖氨酸时,15.5 kDa和15.0 kDa蛋白质的合成被消除,尽管23.5 kDa CbMip的合成完好无损。这证实了15.5 kDa和15.0 kDa蛋白质确实是通过翻译重新起始产生的,而不是23.5 kDa蛋白质的降解产物。与其他FKBPs一样,15.5 kDa和15.0 kDa蛋白质都具有PPIase活性。由于它们与FKBPs具有显著的序列同源性且具有相似的PPIase活性,15.5 kDa和15.0 kDa蛋白质分别被命名为伯纳特立克次体FKBP(Cb-FKBP)类似物I和II。TnphoA诱变表明,大蛋白(CbMip)是分泌型的,而Cb-FKBP类似物I和II是胞质型的,这表明结构变异可能导致相似蛋白质在不同的亚细胞区室化。使用CbMip特异性单克隆抗体对纯化的伯纳特立克次体裂解物进行的蛋白质印迹分析显示,存在一种迁移约15 kDa的蛋白质,这表明在伯纳特立克次体中存在较小的Cb-FKBP类似物,尽管其水平与23.5 kDa CbMip相比要低得多。cbmip基因所呈现的这种独特基因组织可能为该生物体提供了一种有效利用其有限遗传信息来合成结构不同但功能相似蛋白质的机制。